Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Freund John Gordon
Relationship:  
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   11    
Direct Shares   2,256,169    

Indirect Shares

   9,013,510      
Direct Value   $7,785,612    

Indirect Value

   $20,049,534      
Total Shares   11,269,679      
Total Value   $27,835,146      


Map Pharmaceuticals Inc $0 Protara Therapeutics, Inc $6,092,470 Collegium Pharmaceutical, Inc $1,693,142 Si-Bone, Inc. $0 Map Pharmaceuticals Inc $0 Protara Therapeutics, Inc $6,092,470 Collegium Pharmaceutical, Inc $1,693,142 Si-Bone, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    3    

     Stock price went up :
    0   
    3    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   3.0   
     Percentage Gain/Loss :
     0.0%
 257.3%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Xenoport Inc XNPT Director 2016-07-05 0 2016-07-05 0    Premium*  
            Hansen Medical Inc HNSN Director 2006-11-21 0 2009-04-17 2,000,936    Premium*  
            Map Pharmaceuticals Inc MAPP Director, 10% Owner 2011-02-14 1,984 2011-05-20 5,152    Premium*  
            Mako Surgical Corp. MAKO Director 0 2013-12-17 0    Premium*  
            Acelrx Pharmaceuticals Inc ACRX 10% Owner 2011-02-16 0 2012-05-29 4,161,933    Premium*  
            Tetraphase Pharmaceuticals Inc TTPH Director 2019-12-10 0 2019-12-10 0    Premium*  
            Concert Pharmaceuticals, Inc. CNCE Director, 10% Owner 0 2014-02-20 1,208,920    Premium*  
            Protara Therapeutics, Inc TARA Director 2019-11-08 2,175,882 2014-10-27 1,432,930    Premium*  
            Collegium Pharmaceutical, Inc COLL Director 2024-05-16 52,468 2024-05-16 43,413    Premium*  
            Sutro Biopharma Inc STRO Director 2018-10-01 0 2020-12-10 56,327    Premium*  
            Si-Bone, Inc. SIBN 2023-08-09 25,835 2023-08-09 103,899    Premium*  
* Premium Members only  

Records found :    141         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
CNCE Concert Pharmaceuticals, ... Director   –       •       •   2014-02-20 4 B $14.00 $2,100,000 I/I 150,000 1,208,920 2.25 -
TTPH Tetraphase Pharmaceutical... Former 10% Owner   –       •      –    2014-03-12 4 A $0.00 $0 I/I 4,493 4,493 0 -
TTPH Tetraphase Pharmaceutical... Former 10% Owner   –       •      –    2014-03-12 4 D $0.00 $0 I/I (300,000) 1,890,146 0 -
TTPH Tetraphase Pharmaceutical... Director   –       •      –    2014-05-14 4 D $0.00 $0 I/I (4,493) 0 0 -
TTPH Tetraphase Pharmaceutical... Director   –       •      –    2014-05-14 4 A $0.00 $0 I/I 3,006 3,006 0 -
XNPT Xenoport Inc Director   –       •      –    2014-05-14 4 OE $0.00 $0 D/D 5,000 8,899 0 -
XNPT Xenoport Inc Director   –       •      –    2014-05-22 4 B $3.75 $20,623 I/I 5,500 11,700 2.1 -
XNPT Xenoport Inc Director   –       •      –    2014-05-23 4 B $3.72 $35,354 I/I 9,500 21,200 2.1 -
XNPT Xenoport Inc Director   –       •      –    2014-06-03 4 B $3.93 $49,164 I/I 12,500 22,633 2.1 -
TTPH Tetraphase Pharmaceutical... Director   –       •      –    2014-06-19 4 AS $13.08 $916,712 I/I (70,100) 1,820,046 0 -
TTPH Tetraphase Pharmaceutical... Director   –       •      –    2014-06-20 4 AS $13.65 $1,128,933 I/I (82,716) 1,737,330 0 -
TTPH Tetraphase Pharmaceutical... Director   –       •      –    2014-06-23 4 AS $13.77 $649,889 I/I (47,184) 1,690,146 0 -
TTPH Tetraphase Pharmaceutical... Director   –       •      –    2014-09-03 4 AS $15.04 $2,137,241 I/I (142,100) 1,548,046 0 -
TTPH Tetraphase Pharmaceutical... Director   –       •      –    2014-09-04 4 AS $15.06 $620,596 I/I (41,200) 1,506,846 0 -
TTPH Tetraphase Pharmaceutical... Director   –       •      –    2014-09-05 4 AS $15.01 $183,532 I/I (12,227) 1,494,619 0 -
TTPH Tetraphase Pharmaceutical... Director   –       •      –    2014-09-08 4 AS $15.01 $67,126 I/I (4,473) 1,490,146 0 -
TTPH Tetraphase Pharmaceutical... Director   –       •      –    2014-09-11 4 AS $17.00 $35,708 I/I (2,100) 1,488,046 0 -
TTPH Tetraphase Pharmaceutical... Director   –       •      –    2014-09-12 4 AS $17.01 $910,757 I/I (53,544) 1,434,502 0 -
TTPH Tetraphase Pharmaceutical... Director   –       •      –    2014-09-16 4 AS $17.03 $1,147,140 I/I (67,356) 1,367,146 0 -
TTPH Tetraphase Pharmaceutical... Director   –       •      –    2014-09-17 4 AS $17.36 $1,336,597 I/I (77,000) 1,290,146 0 -
TTPH Tetraphase Pharmaceutical... Director   –       •      –    2014-09-29 4 AS $20.19 $1,931,334 I/I (95,648) 1,194,498 0 -
TTPH Tetraphase Pharmaceutical... Director   –       •      –    2014-09-30 4 AS $20.17 $1,141,844 I/I (56,618) 1,137,880 0 -
TTPH Tetraphase Pharmaceutical... Director   –       •      –    2014-10-01 4 AS $20.41 $2,962,731 I/I (142,146) 995,734 0 -
TTPH Tetraphase Pharmaceutical... Director   –       •      –    2014-10-02 4 AS $20.72 $2,211,146 I/I (105,588) 890,146 0 -
TARA Protara Therapeutics, Inc Director   –       •       •   2014-10-27 4 B $10.00 $2,000,000 I/I 200,000 200,000 2.25 -
  141  Records found
  1   2   3  4   5   6      
  Page 3 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us